{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T05:04:40Z","timestamp":1747544680051},"reference-count":26,"publisher":"American Public Health Association","issue":"8_Pt_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Public Health"],"published-print":{"date-parts":[[1995,8]]},"abstract":"<jats:p> OBJECTIVE. This study assessed the acceptability of three nonoxynol-9 spermicides among persons attending a sexually transmitted disease clinic in Lusaka, Zambia. METHODS. Spermicidal foam, suppositories, and foaming tablets were evaluated. Women (n = 114) and men (n = 150) attending an sexually transmitted disease clinic were enrolled. After each participant used two products, each for 2 weeks, consistency of use and acceptability were evaluated. RESULTS. At admission, most women (74%) and men (58%) were not using any family planning method. Moreover, most women (85%) and men (98%) had at least one sexually transmitted disease or genital infection. During the study, the proportion of coital episodes protected by spermicide use was high, yet loss to follow-up and discontinuation were also substantial. Discontinuation was frequently unrelated to acceptability. Women and men rated all three products positively along several acceptability parameters. Foam was the least desirable delivery system due to excess messiness. CONCLUSIONS. The results of this study suggest that it is feasible to distribute spermicides to women and men at increased risk for sexually transmitted disease and that the products will be used. Further research should be done among different populations and include other spermicidal delivery mechanisms. <\/jats:p>","DOI":"10.2105\/ajph.85.8_pt_1.1098","type":"journal-article","created":{"date-parts":[[2008,11,29]],"date-time":"2008-11-29T13:18:52Z","timestamp":1227964732000},"page":"1098-1103","source":"Crossref","is-referenced-by-count":17,"title":["Spermicide acceptability among patients at a sexually transmitted disease clinic in Zambia."],"prefix":"10.2105","volume":"85","author":[{"given":"S K","family":"Hira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A B","family":"Spruyt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P J","family":"Feldblum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M R","family":"Sunkutu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L H","family":"Glover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M J","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"844","reference":[{"key":"p_1","unstructured":"Lande R. Controlling Sexually Transmitted Diseases. Baltimore, Md: Johns Hopkins School of Public Health, Population Information Program; June 1993. Pop Reports, Series L, No.9."},{"key":"p_2","doi-asserted-by":"publisher","DOI":"10.2307\/2135469"},{"key":"p_3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199408113310601"},{"key":"p_4","doi-asserted-by":"publisher","DOI":"10.1126\/science.1439818"},{"key":"p_5","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.77.11.1427"},{"key":"p_6","doi-asserted-by":"publisher","DOI":"10.2307\/2135542"},{"key":"p_7","doi-asserted-by":"publisher","DOI":"10.2307\/2136004"},{"key":"p_8","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(86)90108-0"},{"key":"p_9","doi-asserted-by":"crossref","unstructured":"Alexander NJ. Sexual transmission of human immunodeficiency virus: Virus entry into the male and female genital tract. FertilSteriL 1990;54:1-18.","DOI":"10.1016\/S0015-0282(16)53628-0"},{"key":"p_10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1987.03390170064029"},{"key":"p_11","doi-asserted-by":"crossref","unstructured":"Louv WC, Austin H, Alexander WJ, Stagno S, Cheeks J. A clinical trial of nonoxyno1-9 for preventing gonococcal and chlamydial infections.JInfectDis. 1988;158: 518-523.","DOI":"10.1093\/infdis\/158.3.518"},{"key":"p_12","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91195-E"},{"key":"p_13","doi-asserted-by":"crossref","unstructured":"Kelaghan J, Rubin GL, Ory HW, Layde PM. Barrier-method contraceptives and pelvic inflammatory disease. JAAL4. 1982; 248:184-187.","DOI":"10.1001\/jama.248.2.184"},{"key":"p_14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1984.03340450038023"},{"key":"p_15","doi-asserted-by":"crossref","unstructured":"Rosenberg MJ, Gollub EL. Commentary: methods women can use that may prevent sexually transmitted disease, including HIV. AmJPublicHealth. 1992;82:1473-1478.","DOI":"10.2105\/AJPH.82.11.1473"},{"key":"p_16","first-page":"589","volume":"42","author":"Centers for Disease Control and Prevention. Update","year":"1993","journal-title":"MMWR"},{"key":"p_17","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92258-U"},{"key":"p_18","first-page":"165","volume":"4","author":"Roddy R","year":"1993","journal-title":"IntJSTDAIDS."},{"key":"p_19","doi-asserted-by":"crossref","unstructured":"Kreiss J, Ngugi E, Holmes K, etal. Efficacy of nonoxyno1-9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes.JAM4. 1992;268:477-482.","DOI":"10.1001\/jama.268.4.477"},{"key":"p_20","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199305000-00018"},{"key":"p_21","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.84.6.1032-a"},{"key":"p_22","unstructured":"New York State Department of Health. Focus on AIDS in New York State: A Newsletter of the New York State Department of Health AIDS Institute. July 1992."},{"key":"p_23","unstructured":"Feldblum P, Ryan K, D'Atre A, Roddy R. Local discomfort with single or multiple doses of spermicides. Presented at the Workshop on Contraceptive Efficacy and STD Prevention: Issues in the Design of Clinical Trials; April 6-8, 1994; Bethesda, Md; sponsored by the National Institute of Child Health and Human Development, the Centers for Disease Control and Prevention, and the Food and Drug Administration."},{"key":"p_24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199208203270822"},{"key":"p_25","unstructured":"Hatcher RA, Trussell J, Stewart F, etal Contraceptive Technology. 16th revised ed. New York, NY: Irvington Publishers; 1994."},{"key":"p_26","unstructured":"Steiner M, Spruyt A, Joanis C, etal. Acceptability study of two nonoxyno1-9 products in Kenya, the Dominican Republic and Mexico. Int Fam Plann Perspect. In press."}],"container-title":["American Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ajph.aphapublications.org\/doi\/pdf\/10.2105\/AJPH.85.8_Pt_1.1098","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T21:26:22Z","timestamp":1652131582000},"score":1,"resource":{"primary":{"URL":"https:\/\/ajph.aphapublications.org\/doi\/full\/10.2105\/AJPH.85.8_Pt_1.1098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,8]]},"references-count":26,"journal-issue":{"issue":"8_Pt_1","published-print":{"date-parts":[[1995,8]]}},"alternative-id":["10.2105\/AJPH.85.8_Pt_1.1098"],"URL":"https:\/\/doi.org\/10.2105\/ajph.85.8_pt_1.1098","relation":{},"ISSN":["0090-0036","1541-0048"],"issn-type":[{"value":"0090-0036","type":"print"},{"value":"1541-0048","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,8]]}}}